IPO registrations (S-1, F-1) · Registrants

EOM Pharmaceutical Holdings, Inc.

SEC CIK
822411 · filings on EDGAR ↗
Former names
ImmunoCellular Therapeutics, Ltd. (2006–2022); Optical Molecular Imaging, Inc (2006–2006); PATCO INDUSTRIES LTD (1999–2006)
Registration
Form S-1, first filed 2008-04-16, last 2022-12-20; 9 initial registrations, 15 amendments
Outcome
Final prospectus filed 2012-01-11; declared effective 2008-05-05; withdrawal requested 2023-08-02
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
30721 RUSSELL RANCH ROAD, SUITE 140, Westlake Village, CA 91362
EIN
93-1301885
EDGAR entity type
operating
Insiders and CEO pay
EOM Pharmaceutical Holdings, Inc. on the corporate pages

Offering terms

Final price
$1.10 per share (424B4 filed 2012-01-11)
Shares sold
9,489,436
Gross proceeds
$10,438,379 before underwriting discounts and any over-allotment option
Listing
OTC under the symbol IMUC
Lead underwriters
Cowen
Syndicate
Summer Street Research Partners

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 54

FiledFormWhat it isName as filedEDGAR
2008-04-16S-1S-1 (registration)ImmunoCellular Therapeutics, Ltd.0001193125-08-082842 ↗
2008-05-05EFFECTEFFECT (declared effective)ImmunoCellular Therapeutics, Ltd.9999999995-08-001450 ↗
2008-05-13EFFECTEFFECT (declared effective)ImmunoCellular Therapeutics, Ltd.9999999995-08-001543 ↗
2009-05-14EFFECTEFFECT (declared effective)ImmunoCellular Therapeutics, Ltd.9999999995-09-001402 ↗
2009-06-19EFFECTEFFECT (declared effective)ImmunoCellular Therapeutics, Ltd.9999999995-09-001706 ↗
2009-12-23S-1S-1 (registration)ImmunoCellular Therapeutics, Ltd.0001193125-09-259142 ↗
2010-01-22EFFECTEFFECT (declared effective)ImmunoCellular Therapeutics, Ltd.9999999995-10-000296 ↗
2010-05-28S-1S-1 (registration)ImmunoCellular Therapeutics, Ltd.0000950130-10-001484 ↗
2010-06-23EFFECTEFFECT (declared effective)ImmunoCellular Therapeutics, Ltd.9999999995-10-001914 ↗
2010-07-06EFFECTEFFECT (declared effective)ImmunoCellular Therapeutics, Ltd.9999999995-10-002045 ↗
2010-07-06EFFECTEFFECT (declared effective)ImmunoCellular Therapeutics, Ltd.9999999995-10-002048 ↗
2010-10-13EFFECTEFFECT (declared effective)ImmunoCellular Therapeutics, Ltd.9999999995-10-002911 ↗
2011-04-05S-1S-1 (registration)ImmunoCellular Therapeutics, Ltd.0001193125-11-089221 ↗
2011-04-26EFFECTEFFECT (declared effective)ImmunoCellular Therapeutics, Ltd.9999999995-11-001161 ↗
2011-04-26EFFECTEFFECT (declared effective)ImmunoCellular Therapeutics, Ltd.9999999995-11-001170 ↗
2011-05-12EFFECTEFFECT (declared effective)ImmunoCellular Therapeutics, Ltd.9999999995-11-001498 ↗
2011-11-29S-1S-1 (registration)ImmunoCellular Therapeutics, Ltd.0001193125-11-324516 ↗
2011-12-09S-1/AS-1/A (amendment)ImmunoCellular Therapeutics, Ltd.0001193125-11-335356 ↗
2011-12-22S-1/AS-1/A (amendment)ImmunoCellular Therapeutics, Ltd.0001193125-11-350921 ↗
2011-12-29S-1/AS-1/A (amendment)ImmunoCellular Therapeutics, Ltd.0001193125-11-355719 ↗
2011-12-30EFFECTEFFECT (declared effective)ImmunoCellular Therapeutics, Ltd.9999999995-12-000026 ↗
2012-01-11424B4424B4 (final prospectus)ImmunoCellular Therapeutics, Ltd.0001193125-12-008271 ↗
2012-05-09EFFECTEFFECT (declared effective)ImmunoCellular Therapeutics, Ltd.9999999995-12-001469 ↗
2012-05-09EFFECTEFFECT (declared effective)ImmunoCellular Therapeutics, Ltd.9999999995-12-001472 ↗
2012-05-09EFFECTEFFECT (declared effective)ImmunoCellular Therapeutics, Ltd.9999999995-12-001476 ↗
2012-06-25EFFECTEFFECT (declared effective)ImmunoCellular Therapeutics, Ltd.9999999995-12-001925 ↗
2012-10-09EFFECTEFFECT (declared effective)ImmunoCellular Therapeutics, Ltd.9999999995-12-002933 ↗
2014-12-12S-1S-1 (registration)ImmunoCellular Therapeutics, Ltd.0001193125-14-440396 ↗
2015-01-21S-1/AS-1/A (amendment)ImmunoCellular Therapeutics, Ltd.0001193125-15-016355 ↗
2015-02-10S-1/AS-1/A (amendment)ImmunoCellular Therapeutics, Ltd.0001193125-15-039761 ↗
2015-02-11S-1/AS-1/A (amendment)ImmunoCellular Therapeutics, Ltd.0001193125-15-044137 ↗
2015-02-11EFFECTEFFECT (declared effective)ImmunoCellular Therapeutics, Ltd.9999999995-15-000389 ↗
2015-02-12424B4424B4 (final prospectus)ImmunoCellular Therapeutics, Ltd.0001193125-15-045685 ↗
2016-01-19EFFECTEFFECT (declared effective)ImmunoCellular Therapeutics, Ltd.9999999995-16-003541 ↗
2016-06-01S-1S-1 (registration)ImmunoCellular Therapeutics, Ltd.0001628280-16-016887 ↗
2016-07-11S-1/AS-1/A (amendment)ImmunoCellular Therapeutics, Ltd.0001628280-16-017552 ↗
2016-08-03S-1/AS-1/A (amendment)ImmunoCellular Therapeutics, Ltd.0001628280-16-018311 ↗
2016-08-04S-1/AS-1/A (amendment)ImmunoCellular Therapeutics, Ltd.0001628280-16-018428 ↗
2016-08-04EFFECTEFFECT (declared effective)ImmunoCellular Therapeutics, Ltd.9999999995-16-005347 ↗
2016-08-08EFFECTEFFECT (declared effective)ImmunoCellular Therapeutics, Ltd.9999999995-16-005376 ↗
2016-08-11424B4424B4 (final prospectus)ImmunoCellular Therapeutics, Ltd.0001628280-16-018870 ↗
2016-08-15EFFECTEFFECT (declared effective)ImmunoCellular Therapeutics, Ltd.9999999995-16-005441 ↗
2016-12-28S-1S-1 (registration)ImmunoCellular Therapeutics, Ltd.0001628280-16-022164 ↗
2017-04-04S-1/AS-1/A (amendment)ImmunoCellular Therapeutics, Ltd.0001628280-17-003307 ↗
2017-06-12S-1/AS-1/A (amendment)ImmunoCellular Therapeutics, Ltd.0001628280-17-006359 ↗
2017-07-10S-1/AS-1/A (amendment)ImmunoCellular Therapeutics, Ltd.0001628280-17-006965 ↗
2017-07-13S-1/AS-1/A (amendment)ImmunoCellular Therapeutics, Ltd.0001628280-17-007028 ↗
2017-07-17EFFECTEFFECT (declared effective)ImmunoCellular Therapeutics, Ltd.9999999995-17-001832 ↗
2017-07-20424B4424B4 (final prospectus)ImmunoCellular Therapeutics, Ltd.0001628280-17-007150 ↗
2018-11-15EFFECTEFFECT (declared effective)ImmunoCellular Therapeutics, Ltd.9999999995-18-002892 ↗
2022-06-24S-1S-1 (registration)ImmunoCellular Therapeutics, Ltd.0001493152-22-017701 ↗
2022-08-10S-1/AS-1/A (amendment)ImmunoCellular Therapeutics, Ltd.0001493152-22-021859 ↗
2022-12-20S-1/AS-1/A (amendment)EOM Pharmaceutical Holdings, Inc.0001493152-22-035920 ↗
2023-08-02RWRW (withdrawal request)EOM Pharmaceutical Holdings, Inc.0001493152-23-026431 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2011-12-29S-1/Aregistration statement$1.0710,000,000$10,700,000OTC IMUC2primary document; price line, shares headline, proceeds computed, cover names 2document ↗
2012-01-11424B4final prospectus$1.109,489,436$10,438,379OTC IMUC2primary document; price sentence, shares headline, proceeds computed, cover names 2document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Bender James G.OfficerVP Product Development & Mfg.; VP, Product Development & Mfg.72012–2013
BRANDWYNNE JACQUELINEDirector12012
Chin RichardDirector42012–2014
COWELL RICHARDDirector32012–2013
FRACTOR DAVIDOfficerChief Financial Officer; Principal Accounting Officer; See Remarks; VP of Finance72012–2016
Kim Helen SusanDirector42012–2014
Singh ManishDirector,OfficerPresident & CEO12012
Singhvi RahulDirector72012–2016
Yu John SDirector; Director,OfficerSecretary; See Remarks132012–2018
Gengos AndrewDirector; Director,OfficerPresident and CEO122012–2017
Titus GaryDirector; Director,OfficerChairman and Secretary82013–2016
Gringeri AnthonyOfficerSenior VP Strategic Resources; Sr. VP, Strategic Resources92013–2016
Swanson Steven JOfficerSenior Vice President, Researc32015–2016
LAPOINTE ANTHONY GREGGDirector32015–2016
SCHLOSSBERG MARK ADirector32015–2016

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2022-09-12ImmunoCellular Therapeutics, Ltd.Pharmaceuticals$5,000,000$750,00011

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Plan sponsorIMMUNOCELLULAR THERAPEUTICS, LTD.CAForm 5500 (employee benefit plans)EIN (EXACT)
Form D issuerImmunoCellular Therapeutics, Ltd.NJForm D private offeringsCIK (EXACT)
SEC filerImmunoCellular Therapeutics, Ltd.SEC filers (EDGAR)CIK (EXACT)
Form 5500 plan sponsorIMMUNOCELLULAR THERAPEUTICS, LTD.EIN (EXACT)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, CA first:

More with this interest.

In other datasets, the same topic (Health) in CA:

Interests: Pharmaceutical Preparations · Health